Stock Scorer

NU Skin Enterprises, Inc. (NUS) · Peers

NU Skin Enterprises against the 10 other companies here in its SEC industry, Wholesale-Drugs, Proprietaries & Druggists' Sundries. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 11, highest first.

Measure by measure

MeasureNUSPeer medianRank
Market value $246.79M median $27.14M 5 of 11
Forward P/E 6.2× median 19.5× 4 of 5
EV/EBITDA 7.0× median 17.5× 5 of 6
P/S 0.2× median 0.3× 10 of 11
FCF yield 4.4% median 5.9% 7 of 11
Dividend yield 4.7% median 0.7% 1 of 4
Gross margin 69.2% median 7.1% 3 of 11
Operating margin -0.8% median -12.1% 6 of 11
Net margin -15.7% median -16.6% 6 of 11
ROIC -1.4% median 10.5% 6 of 9
ROE -39.9% median -48.7% 3 of 5
Revenue growth (4y, yearly) -13.8% median 3.8% 8 of 8
EPS growth (yearly) 2.7% median 1.9% 2 of 4
Net debt / EBITDA 0.7× median 2.3× 5 of 6
Current ratio 2.0× median 0.9× 2 of 11
Stock pay / revenue 1.0% median 1.9% 6 of 11
Share count change 1.3% median 38.6% 7 of 10

Green where NU Skin Enterprises is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.

The peers, largest first

CompanyMarket valueP/EROICScore
NUSNU Skin Enterprises, Inc. $246.79M P/E – -1.4% 5.0
MCKMcKesson Corporation $116.95B P/E 25.5× 998.3% 7.4
CORCencora, Inc. $64.93B P/E 41.8× 19.6% 6.0
CAHCardinal Health Inc $58.55B P/E 34.2× 218.0% 7.1
HLFHerbalife Ltd. $1.53B P/E 9.3× 32.8% 6.6
COSMCosmos Health Inc. $33.57M P/E – -65.7% 4.1
HWHHWH International Inc. $20.71M P/E – -204.9% 2.7
MEDSDataMeds AI, Inc. $8.91M P/E – -191.1% 1.7
HKPDCellyan Biotechnology Co., Ltd $4.65M P/E – 1.4% 5.0
NASCCan B Corp $981,536 P/E – – 2.9
STEKStemtech Corp $299,703 P/E – – 3.0

The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.